Denti Aldo Mariano Roberto 4
4 · DENTSPLY SIRONA Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
DENTSPLY SIRONA (XRAY) EVP Denti Aldo Mariano Roberto Receives Award
What Happened
- Denti Aldo Mariano Roberto, EVP & Chief Commercial Officer of DENTSPLY SIRONA, received equity awards on March 4, 2026: 59,524 restricted stock units (RSUs) and 270,200 derivative awards (stock options). Both awards were recorded at $0.00 cash outlay (they are grants, not purchases or sales).
Key Details
- Transaction date: 2026-03-04; Form filed: 2026-03-06 (filing appears timely).
- RSUs: 59,524 shares granted (footnote F1). No cash paid; value realized only as RSUs vest and convert to shares.
- Derivative awards: 270,200 units (footnote F2) described as stock options. Exercise price = 110% of the issuer’s closing stock price on the grant date.
- Vesting: Both awards vest in equal one-third annual installments over three years, with final vesting by March 4, 2029.
- Shares owned after the transaction: not disclosed in the provided filing excerpt.
Context
- RSUs convert to common shares as they vest; they have value only if the executive remains employed through vesting dates (and then depending on the stock price).
- The derivative awards are options requiring the holder to pay the exercise price (110% of the grant-date close) to acquire shares; they only have intrinsic value if the stock rises above that exercise price.
- These grants are compensation awards and do not reflect an open-market buy or sale by the insider.
Insider Transaction Report
Form 4
Denti Aldo Mariano Roberto
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
[F1]2026-03-04+59,524→ 59,524 total - Award
Stock Option (Right to Buy)
[F2]2026-03-04+270,200→ 270,200 totalExercise: $14.78From: 2027-03-04Exp: 2036-03-04→ Common Stock (270,200 underlying)
Footnotes (2)
- [F1]Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029.
- [F2]Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.
Signature
/s/ Jessica Nielsen Causey, Attorney-In-Fact for Aldo Mariano Roberto Denti|2026-03-06